Narrative review / 2020
Potassium-enriched salt substitutes lower systolic and diastolic blood pressure, but evidence on hyperkalemia risk remains insufficient.
This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.
- Study type
- Narrative review
- Who was studied
- Human populations (specific count not stated)
- What was measured
- Blood pressure, dietary sodium and potassium intake, risk of hyperkalemia
THE PAPER
Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure: Benefits and Risks.
Greer RC, Marklund M, Anderson CAM, Cobb LK, Dalcin AT, Henry M, Appel LJ. Hypertension, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.